Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bionano Genomics's enterprise value was $3.04M on Nov 11, 2026, against -$3.58M a year earlier. Over the last 5 years it ranged from -$31.20M to $531.87M, with a median of $8.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.04M | – |
| 2025 | Dec 31, 2025 | -$6.69M | -149.4% |
| 2024 | Dec 31, 2024 | $13.56M | +321.7% |
| 2023 | Dec 29, 2023 | $3.21M | -98.7% |
| 2022 | Dec 30, 2022 | $253.20M | -50.9% |
| 2021 | Dec 31, 2021 | $515.27M | +13.5% |
| 2020 | Dec 31, 2020 | $453.97M | +1786.6% |
| 2019 | Dec 31, 2019 | $24.06M | -41.2% |
| 2018 | Dec 31, 2018 | $40.91M | – |
See a number that looks wrong?